Torry R J, Labarrere C A, Nelson D, Carter C, Haag B, Faulk W P
Methodist Research Institute, Clarian Health, Inc., Indianapolis, Indiana 46202, USA.
Transplantation. 1998 Sep 27;66(6):797-9. doi: 10.1097/00007890-199809270-00016.
Antithrombin is found in the microvasculature and tubules of normal and transplanted human kidneys. Although depletion of vascular antithrombin is associated with renal allograft dysfunction, neither the distribution nor clinical significance of tubular antithrombin is known.
Changes in tubular antithrombin in biopsy specimens (n=41) obtained from donor kidneys at transplantation were studied immunohistochemically. The relationship between these changes and subsequent graft function was analyzed.
Granular intracellular antithrombin was found only within the proximal tubular epithelium. Allografts with depleted tubular antithrombin at transplantation (n=20) had significantly greater plasma creatinine concentrations at posttransplant days 3 (P < 0.001) and 5 (P < 0.03) than allografts with normal tubular antithrombin (n=21). Indeed, depletion of tubular antithrombin at transplantation correlated with the degree of graft dysfunction at 3 days after transplantation.
Depleted tubular antithrombin at transplantation is associated with reduced early graft function, and this may identify patients at risk of a complicated follow-up.
抗凝血酶存在于正常及移植后的人肾微血管和肾小管中。尽管血管抗凝血酶的消耗与肾移植功能障碍相关,但肾小管抗凝血酶的分布及临床意义尚不清楚。
采用免疫组织化学方法研究了移植时取自供体肾活检标本(n = 41)中肾小管抗凝血酶的变化。分析了这些变化与随后移植肾功能之间的关系。
仅在近端肾小管上皮细胞内发现颗粒状细胞内抗凝血酶。移植时肾小管抗凝血酶缺失的同种异体肾移植(n = 20)在移植后第3天(P < 0.001)和第5天(P < 0.03)的血浆肌酐浓度显著高于肾小管抗凝血酶正常的同种异体肾移植(n = 21)。事实上,移植时肾小管抗凝血酶的缺失与移植后3天的移植功能障碍程度相关。
移植时肾小管抗凝血酶缺失与早期移植功能降低有关,这可能有助于识别有复杂随访风险的患者。